Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 7/20 | 0.44 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | PKM | P14618 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | MMP8 | P22894 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2240802 | 0.92 | FDPS (0.43) | FDPSCYP4F2CYP4A11MEN1KMT2A | |
| SCHEMBL2237636 | 0.89 | FDPS (0.43) | FDPSCYP4F2CYP4A11MEN1KMT2A | |
| SCHEMBL16048 | 0.88 | CYP4F2 (0.40) | CYP4F2CYP4A11MEN1KMT2APKM | |
| SCHEMBL18759662 | 0.88 | CYP4F2 (0.40) | CYP4F2CYP4A11MEN1KMT2APKM | |
| SCHEMBL2043413 | 0.87 | FDPS (0.42) | FDPSGGPS1 | |
| SCHEMBL413276 | 0.86 | CYP4F2 (0.39) | CYP4F2CYP4A11MEN1KMT2APKM | |
| SCHEMBL19278938 | 0.86 | CYP4F2 (0.39) | CYP4F2CYP4A11MEN1KMT2APKM | |
| SCHEMBL2051228 | 0.86 | MEN1 (0.49) | FDPSCYP4F2CYP4A11MEN1KMT2A | |
| SCHEMBL2046239 | 0.86 | MEN1 (0.49) | FDPSCYP4F2CYP4A11MEN1KMT2A | |
| SCHEMBL2043818 | 0.86 | MEN1 (0.49) | FDPSCYP4F2CYP4A11MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 697 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115536719-A | Synthetic method of high-purity plant source 7-ketolithocholic acid | 江苏佳尔科药业集团股份有限公司 | 2022-12-30 | — | — | CN | claimed |
| CN-115246867-A | Method for synthesizing 7-ketolithocholic acid by taking BA as raw material | 江苏佳尔科药业集团股份有限公司 | 2022-10-28 | — | — | CN | claimed |
| WO-2021109791-A1 | METHOD FOR SYNTHESIZING URSODEOXYCHOLIC ACID USING BA AS RAW MATERIAL | 江苏佳尔科药业集团股份有限公司 | 2021-06-10 | — | — | WO | claimed |
| EP-1017687-A4 | PROCESS OF MAKING 3-ARYLOXY, 4-ARYL FURAN-2-ONES USEFUL AS INHIBITORS OF COX-2 | MERCK & CO INC (US) | 2001-10-31 | — | — | EP | claimed |
| EP-1017687-A1 | PROCESS OF MAKING 3-ARYLOXY, 4-ARYL FURAN-2-ONES USEFUL AS INHIBITORS OF COX-2 | Merck & Co., Inc. (US) | 2000-07-12 | — | — | EP | claimed |
| WO-1999015513-A1 | PROCESS OF MAKING 3-ARYLOXY, 4-ARYL FURAN-2-ONES USEFUL AS INHIBITORS OF COX-2 | MERCK & CO., INC. (US) | 1999-04-01 | — | — | WO | claimed |
| JP-60152556-A | — | — | None | — | — | JP | disclosed |
| US-12637430-B2 | Interleukin-17 (IL-17) inhibitors | HITGEN INC. (CN) | 2026-05-26 | — | — | US | disclosed |
| CN-122010730-A | Preparation method of key intermediate of Lutrepah | 重庆常捷医药有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-12492356-B2 | Oxa-sandalwood-type fragrance compounds | SYMRISE AG (DE) | 2025-12-09 | — | — | US | disclosed |
| EP-4177249-B1 | IMMUNOMODULATOR | HITGEN INC (CN) | 2025-12-03 | — | — | EP | disclosed |
| US-20250313557-A1 | IMIDAZO[4,5-C]PYRIDINE DERIVATIVE COMPOUNDS AS TLR7/8 MODULATORS | LIGACHEM BIOSCIENCES INC. (KR) | 2025-10-09 | — | — | US | disclosed |
| US-12410113-B2 | Sandalwood-type fragrance compounds | SYMRISE AG (DE) | 2025-09-09 | — | — | US | disclosed |
| US-4376124-A | Method for modulating the immune response with dibenzocycloheptenylidenes | AMERICAN HOME PRODUCTS CORPORATION (US) | 1983-03-08 | — | — | US | disclosed |
| WO-1981002519-A1 | METHOD FOR TREATING INFLAMMATION | AMERICAN HOME PROD (US) | 1981-09-17 | — | — | WO | disclosed |
| EP-0035903-A1 | Dibenzocycloheptenylidenes and their use in pharmaceutical compositions | AMERICAN HOME PRODUCTS CORPORATION (US) | 1981-09-16 | — | — | EP | disclosed |
| US-4267192-A | BY ADMINISTERING AN UNSATURATED DIBENZOCYCLOHEPTENE ACID OR ESTER COMPOUND | AMERICAN HOME PRODUCTS CORPORATION (US) | 1981-05-12 | — | — | US | disclosed |
| US-4265769-A | CORROSION RESISTANCE, ANTISCALING AGENTS | CIBA-GEIGY CORPORATION (US) | 1981-05-05 | — | — | US | disclosed |
| US-4208344-A | CORROSION RESISTANCE, ANTISCALING AGENTS | CIBA-GEIGY CORPORATION (US) | 1980-06-17 | — | — | US | disclosed |
| US-4136197-A | HYPOGLYCAEMICALLY AND HYPOLIPIDAEMICALLY EFFECTIVE N-SUBSTITUTED CARBOXYLIC ACID AMIDES | BOEHRINGER MANNHEIM GMBH (DE) | 1979-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12410113-B2 | Sandalwood-type fragrance compounds | FDFT1, FAAH2, FAAH | FDPS 14/4885CYP4F2 530/4885CYP4A11 206/4885 |
| US-12637430-B2 | Interleukin-17 (IL-17) inhibitors | IL17A, IL2, IL23R | FDPS 2753/4885CYP4F2 383/4885CYP4A11 59/4885 |
| US-12492356-B2 | Oxa-sandalwood-type fragrance compounds | FDFT1, FAAH2, ALDH1A1 | FDPS 54/4885CYP4F2 689/4885CYP4A11 484/4885 |
| US-20250313557-A1 | IMIDAZO[4,5-C]PYRIDINE DERIVATIVE COMPOUNDS AS TLR7/8 MODULATORS | TLR7, TLR8, TLR3 | FDPS 3974/4885CYP4F2 3484/4885CYP4A11 2115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.